April 28, 2026
The first half of 2026 has marked a structural shift in how healthcare innovation is built and financed. Across Europe, hospitals are facing a fundamentally unsustainable operating model driven by severe labor shortages. Up to 60% of hospital operating costs are tied to personnel, and a staggering 75% of facilities are running at a loss. To survive, the healthcare system cannot just optimize existing software; it has to automate the physical world.
At the same time, government backing is amplifying this technological transition. With the EU’s Horizon Europe program explicitly earmarking €180 million for breakthrough technologies, including robotics, we are seeing artificial intelligence move out of the cloud and into the clinic. As healthcare faces these unprecedented staffing challenges, intelligent robotics are transitioning from a futuristic novelty into an immediate clinical necessity.
Historically, medical robotics meant incredibly expensive, single-purpose hardware that was difficult to integrate and scale. Today, we are seeing the ecosystem pivot toward generalized, AI-driven physical automation.
Artificial intelligence is rapidly emerging as the core enabling technology, transforming standard hardware into adaptable, intelligent fleets capable of navigating complex spaces. With hardware costs commoditizing, the real value has shifted toward deep integration and software orchestration. This software-first approach allows healthcare facilities to adopt smarter, more flexible tools that enhance existing clinical workflows without rigidly reprogramming them for every new environment.
The push for physical AI is not isolated to healthcare; sectors like logistics and defense have become major proving grounds for robust automation. A prime example of this industry-wide inflection point is Sereact, which recently secured a Series B led by Headline to fully automate complex pick-and-place processes using advanced Vision Language Action Models.
This cross-industry momentum is helping to create highly specialized regional clusters of excellence across Europe. Cities like Munich and Zurich are demonstrating a strong concentration of robotics innovation. These hubs are building the dense talent pools and engineering infrastructure necessary to scale complex, life-saving systems globally.
While administrative automation is growing, the clinical setting remains a massive driver for innovation. Robotics can drastically expand patient access to high-quality care while simultaneously reducing physician burnout.
Our portfolio company, SquareMind, is a perfect example. They just announced an $18 million Series A led by Sonder Capital to completely redefine modern dermatology. Their Swan™ robot is the world’s first system to capture standardized, full-body dermoscopic imaging in just minutes. By automating the tedious mechanical work of skin documentation, the platform reduces the immense cognitive load on dermatologists. It acts as a companion, allowing physicians to focus entirely on diagnosis and the patient relationship.
The transition from the cloud to the clinic is healthcare’s most exciting and unforgiving frontier. If you are a founder engineering the next generation of physical AI, please reach out to us!